Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

3d ago, source:

GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) --. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage ...

EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patent

on MSN ago, source:

On April 16, 2024, the United States Patent and Trademark Office issued patent number 11957664 to Adial Pharmaceuticals Inc ...

EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance

on MSN ago, source:

Adial Pharmaceuticals Inc (NASDAQ:ADIL) announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered ...

Adial Pharmaceuticals Inc (NASDAQ: ADIL): Why It’s An Attractive Pick Now

9d ago, source:

Adial Pharmaceuticals Inc (NASDAQ:ADIL) price closed higher on Monday, April 15, jumping 12.02% above its previous close.

Adial Pharmaceuticals posts promising update on alcohol disorder drug

15d ago, source: kalkinemedia

Adial Pharmaceuticals Inc (NASDAQ: ADIL) is up 60% today following a promising update on its alcohol disorder drug. What it ...

Adial Pharmaceuticals Inc (ADIL) Shares Decline Despite Market Challenges

10d ago, source: newsheater

Adial Pharmaceuticals Inc (NASDAQ: ADIL)’s stock price has gone decline by -21.81 in comparison to its previous close of 2.98, however, the company has experienced a 100.86% increase in its stock ...

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

23d ago, source: Stockhouse

GLEN ALLEN, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage ...

Adial Pharmaceuticals secures new addiction treatment patent

3d ago, source: Investing

GLEN ALLEN, Va. - Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), a clinical-stage biopharmaceutical company, has been granted a new patent by the United States Patent and Trademark Office as of April 16, ...

Adial Pharmaceuticals Inc ADIL

9d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Adial Pharmaceuticals, Inc: Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

3d ago, source:

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...

Adial Pharmaceuticals Inc (ADIL)

8d ago, source: Investing

Shares of Adial Pharmaceuticals (NASDAQ:ADIL) experienced a significant 24% drop on Friday, following the announcement of definitive agreements for a private placement deal. The... Investing.com ...